everi
year
peopl
unit
state
becom
infect
one
everi
adult
live
hiv
subsaharan
africa
unaid
report
despit
increas
knowledg
hiv
pathogen
interact
immun
system
conundrum
creat
vaccin
pathogen
adult
human
report
complet
clear
infect
consensu
search
effect
vaccin
easi
feat
partli
correl
complet
protect
unclear
howev
like
clinic
signific
infecti
diseas
smallpox
need
vaccin
hiv
utmost
import
manag
global
hiv
epidem
theoret
vaccin
strategi
like
stimul
effect
respons
hiv
would
one
effici
deliv
antigen
host
ii
stimul
robust
humor
cellular
immun
respons
capabl
target
viru
viru
infect
cell
iii
establish
popul
memori
cell
quickli
effici
replic
protect
host
expos
actual
infect
extens
work
done
vaccin
develop
hiv
mice
nonhuman
primat
nhp
unlik
pathogen
attenu
hiv
vaccin
explor
attempt
attenu
siv
prevent
rhesu
macaqu
get
aid
relat
ill
resultingli
mode
antigen
deliveri
explor
live
attenu
viral
vector
particularli
success
deliveri
foreign
antigen
host
distinct
mode
vaccin
subunit
vaccin
dnaplasmid
attenu
live
viral
vector
abl
induc
robust
cellular
humor
respons
larg
due
abil
undergo
sever
round
replic
vivo
date
number
differ
viral
vector
extens
character
studi
signific
vaccin
trial
use
human
fail
result
protect
highrisk
individu
hiv
infect
one
major
drawback
system
thought
presenc
preexist
antibodi
viral
vector
necessit
character
viral
vector
potenti
use
hiv
vaccin
develop
goal
project
present
evalu
three
wellcharacter
nsv
vector
heterolog
homolog
primeboost
experi
studi
multipl
vector
laboratori
environ
also
allow
comparison
made
vector
keep
variabl
static
negativestrand
virus
nsv
compris
four
famili
rhabdovirida
includ
vesicular
stomat
viru
vsv
rabi
viru
rabv
paramyxovirida
includ
newcastl
diseas
viru
ndv
human
parainfluenza
viru
type
sendai
viru
mump
viru
measl
viru
human
respiratori
syncyti
metapneumovirus
filovirida
includ
ebola
viru
marburg
viru
borna
diseas
viru
bornavirida
famili
nsv
advantag
vaccin
vector
replic
cytoplasm
therefor
risk
genet
recombin
host
cell
dna
aforement
virus
rabv
vsv
ndv
wellestablish
candid
hiv
vaccin
develop
schnell
et
al
first
establish
revers
genet
system
allow
recoveri
infecti
rabv
clone
cdna
system
use
obtain
recombin
nsv
includ
vsv
ndv
genom
virus
readili
manipul
express
multipl
foreign
gene
unlik
individu
previous
expos
virus
thu
seroneg
factor
make
rank
highli
potenti
viral
vaccin
candid
addit
virus
extens
studi
potenti
hivsiv
vaccin
vector
shown
induc
potent
immun
respons
rabv
vsv
singlestrand
neg
sens
rna
virus
famili
rhabdovirida
simpl
genom
encod
gene
nucleoprotein
n
phosphoprotein
p
matrix
protein
glycoprotein
g
larg
protein
l
sad
strain
rabv
attenu
strain
use
vaccin
develop
shown
safe
mice
nhp
without
vectorinduc
pathogen
rabv
vaccin
vector
engin
express
envelop
structur
protein
gag
pol
immunogen
mice
nhp
note
nhp
immun
rabv
express
gagpol
env
protect
aidslik
ill
challeng
highli
pathogen
siv
strain
compar
control
neurovirul
anim
model
vsv
vaccin
vector
attenu
make
safe
vaccin
vector
use
sever
differ
approach
vector
use
base
protein
mutant
vsv
wildtyp
vsvm
protein
known
suppress
host
express
gene
need
innat
respons
review
singleamino
acid
substitut
substitut
protein
result
vector
activ
rather
suppress
innat
respons
vector
immunogen
wildtyp
vsv
lack
neurovirul
also
improv
safeti
profil
ndv
avian
paramyxoviru
natur
infect
differ
avian
speci
ndv
strain
classifi
three
categori
accord
virul
poultri
velogen
mesogen
lentogen
lentogen
strain
caus
diseas
poultri
wide
use
live
poultri
vaccin
virul
velogen
strain
ndv
ndv
undergo
limit
round
replic
mammal
due
inabl
inhibit
innat
immun
respons
host
lentogen
strain
ndv
express
foreign
antigen
demonstr
immunogen
multipl
anim
includ
mice
chicken
sheep
cattl
nhp
studi
explor
util
rabv
vsv
ndv
vaccin
vector
gag
heterolog
primeboost
regimen
gag
specif
cell
induct
analyz
differ
primeboost
regimen
found
three
nsv
capabl
boost
immun
respons
one
anoth
ndvgag
vsvgag
induc
significantli
higher
respons
rabv
use
boost
vaccin
notabl
differ
postchalleng
vvgag
gener
three
nsv
compat
primeboost
vaccin
six
eight
week
old
femal
balbc
mice
nih
maintain
thoma
jefferson
univers
anim
facil
anim
handl
strict
accord
good
anim
practic
defin
relev
intern
associ
assess
accredit
laboratori
anim
care
aaalac
accredit
statu
tju
full
nation
regul
tju
anim
welfar
assur
number
anim
work
approv
institut
anim
care
use
committe
iacuc
thoma
jefferson
univers
tju
anim
use
protocol
written
approv
accord
public
health
servic
polici
human
care
use
laboratori
anim
guid
care
use
laboratori
anim
tju
iacuc
protocol
number
vaccin
vector
figur
studi
previous
character
rabvgag
previous
publish
bnspgag
construct
rabvvaccin
vector
express
optim
gag
optgag
use
cdna
publish
character
vector
reveal
lower
level
express
gag
cell
supernat
infect
cell
compar
rabvgag
data
shown
spbniggag
rabv
vector
rabv
glycoprotein
gene
exchang
ectodomain
transmembran
domain
vsv
indiana
strain
fuse
cytoplasm
domain
rabvg
paper
cite
rabviggag
vsvgag
gener
attenu
due
mutat
matrix
protein
gag
vsvgag
vector
codon
optim
gag
codonoptim
gag
gene
amplifi
pcr
use
primer
pcr
product
cleav
pac
clone
pac
site
protein
mutant
vsv
cdna
infecti
clone
describ
infecti
viru
recov
plasmid
dna
viru
stock
prepar
describ
correct
orient
sequenc
insert
confirm
sequenc
plasmid
dna
cdna
prepar
rtpcr
genom
recov
viru
character
vaccin
construct
western
blot
analysi
show
increas
express
level
gag
cell
infect
vector
supernat
data
shown
use
studi
ndv
vector
express
codonoptim
gag
gene
previous
character
publish
design
ndvgag
paper
vero
cell
seed
plate
cell
per
well
day
infect
follow
day
infect
multipl
infect
moi
five
bnspgag
vsvoptgag
ndvoptgag
serumfre
optimem
medium
h
inoculum
remov
replac
ml
fresh
optimem
medium
incub
continu
supernat
collect
time
indic
figur
spun
rpm
min
transfer
fresh
tube
cell
wash
ml
pb
resuspend
lysi
buffer
mm
hepe
ph
mm
nacl
nadoc
mm
edta
supplement
halt
proteas
inhibitor
cocktail
thermoscientif
inc
lysat
centrifug
min
rpm
transfer
fresh
tube
protein
concentr
lysat
measur
bca
kit
thermofish
adjust
addit
lysi
buffer
supernat
lysat
dilut
optimem
pb
respect
assay
retrotek
antigen
elisa
kit
accord
manufactur
instruct
zeptrometrix
buffalo
ny
mice
prime
intramuscularli
im
either
foci
form
unit
ffu
rabvgag
day
ffu
vsvgag
day
ffu
ndvgag
day
administ
two
inject
per
hind
limb
boost
experi
mice
rest
day
prime
boost
im
either
ffu
rabviggag
ffu
vsvgag
ffu
ndvgag
day
receiv
boost
control
n
per
group
pb
mice
includ
neg
control
mice
euthan
day
boost
spleen
harvest
analysi
cellular
respons
challeng
experi
mice
rest
day
boost
challeng
intraperiton
ip
plaqu
form
unit
pfu
recombin
vaccinia
viru
express
gag
arrrp
cite
vvgag
n
per
group
mice
receiv
pb
includ
neg
control
mice
euthan
day
challeng
spleen
harvest
analysi
recal
respons
cell
stain
flow
cytometri
previous
describ
brief
spleen
mous
homogen
singlecel
suspens
splenocyt
obtain
cell
block
hour
fac
buffer
bovin
serum
albumin
pb
contain
fc
block
bd
bioscienc
unconjug
streptavidin
per
cell
order
reduc
nonspecif
bind
streptavidinconjug
tetram
antibodi
cell
wash
twice
fac
buffer
stain
minut
room
temperatur
fluorochromelink
antibodi
cell
surfac
antigen
bd
bioscienc
bd
bioscienc
peamqmlketi
tetram
becton
dickinson
surfac
stain
cell
wash
fix
paraformaldehyd
bdcytofix
buffer
bd
bioscienc
minut
cell
wash
resuspend
fac
buffer
analyz
lsrii
machin
bd
kimmel
cancer
center
cytometri
facil
thoma
jefferson
univers
event
collect
immun
mous
analyz
flow
cytometri
data
splenocyt
cell
first
gate
viabil
use
forward
side
scatter
gate
fac
data
analyz
use
flowjo
version
softwar
function
analysi
cell
splenocytesml
plate
plate
presenc
golgiplug
bd
bioscienc
golgistop
bd
bioscienc
follow
incub
hour
mous
two
group
analyz
antigenstimul
group
puls
amqmlketi
peptid
nonstimul
group
left
without
peptid
cell
incub
fluorochromelink
antibodi
surfac
protein
bd
bioscienc
minut
room
temperatur
cell
wash
fix
paraformaldehyd
bdcytofix
buffer
bd
bioscienc
minut
cell
wash
permwash
buffer
bd
bioscienc
cell
stain
minut
room
temperatur
permwash
buffer
contain
antibodi
intern
antigen
bd
pharmingen
becton
dickinson
cell
resuspend
fac
buffer
fac
analysi
perform
describ
data
analyz
prism
softwar
graphpad
version
statist
analysi
perform
use
unpair
ttest
compar
two
group
repres
twotail
pvalu
confid
interv
oneway
anova
bonferroni
posttest
analysi
use
two
group
compar
present
result
show
mean
measur
within
group
statist
follow
notat
use
indic
signific
two
group
p
p
p
p
vaccin
vector
heterolog
primeboost
approach
rabvgag
rabviggag
express
vsvindiana
g
instead
rabv
g
vsvgag
ndvgag
figur
analyz
gag
express
level
three
vaccin
vector
vero
cell
infect
moi
bnspgag
vsvgag
ndvgag
cell
lysat
figur
supernat
figur
collect
time
indic
antigen
measur
elisa
result
indic
vsvgag
express
highest
amount
gag
wherea
ndv
express
lowest
level
gag
detect
elisa
surprisingli
rabv
express
detect
ndvgag
even
though
rabvbas
vector
contain
codonoptim
gag
util
two
vector
cell
import
effector
cell
control
hiv
along
humor
respons
viru
studi
induct
effect
cell
respons
requir
replic
vector
achiev
adequ
antigen
express
level
prime
boost
phase
heterolog
vaccin
regimen
might
facilit
suffici
replic
vector
enhanc
result
cellular
immun
respons
sinc
avoid
problem
antivector
immun
boost
phase
typic
homolog
primeboost
protocol
analyz
benefit
heterolog
primeboost
approach
immun
mice
rabvgag
follow
second
immun
rabviggag
express
vsvindiana
g
instead
rabv
g
vsvgag
ndvgag
figur
note
throughout
studi
ndvgag
alway
appli
twice
day
apart
initi
ndv
infect
prevent
second
immun
vectorspecif
antibodi
observ
rabv
vsv
two
addit
group
mice
receiv
boost
given
equal
volum
pb
control
follow
boost
immun
percentag
gag
specif
cell
measur
amqmlketi
tetram
activ
cell
figur
function
express
cytokin
cell
analyz
intracellular
cytokin
stain
figur
shown
figur
mice
immun
ndvgag
significantli
higher
induct
gagspecif
cell
compar
vsvgag
p
rabviggag
p
similarli
higher
percentag
activ
cell
mice
boost
ndvgag
express
p
p
p
similar
trend
seen
mice
prime
vsvgag
follow
boost
rabvgag
ndvgag
figur
ndvgag
induc
robust
cell
respons
compar
group
p
figur
express
inflammatori
cytokin
similar
level
activ
p
p
p
figur
mice
prime
ndvgag
follow
heterolog
immun
vsvgag
rabvgag
shown
figur
regimen
increas
cell
respons
ndvgag
compar
control
figur
vsvgag
induc
significantli
gag
specif
cell
rabvgag
p
similar
trend
seen
express
p
tnf
p
p
figur
surprisingli
homolog
respons
ndvgag
lower
rabvgag
vsvgag
note
express
mice
prime
boost
ndvgag
lower
mice
boost
figur
taken
togeth
vsvgag
effect
increas
cell
respons
ndvgag
prime
wherea
increas
seen
similar
level
boost
rabvbas
vaccin
vector
boost
respons
boost
respons
immun
heterolog
vaccin
vector
might
predict
effici
approach
final
goal
vaccin
induct
longterm
memori
cell
control
futur
infect
recal
respons
therefor
mice
prime
rabvgag
follow
heterolog
immun
vector
challeng
vvgag
shown
figur
percentag
gag
cell
figur
well
express
analyz
figur
note
although
ndvgag
induc
robust
cell
respons
use
boost
mice
immun
nsv
mice
boost
ndvgag
lower
recal
respons
vvgag
challeng
differ
ndvgag
vsvgag
cell
statist
signific
p
second
seri
challeng
experi
mice
prime
vsvgag
follow
booster
immun
nsv
challeng
vvgag
figur
gener
challeng
vvgag
result
strong
respons
group
compar
pb
group
induc
gagspecif
cell
subtl
differ
percentag
p
p
cell
evid
compar
boost
group
respons
anim
receiv
vsvgag
prime
third
experiment
group
ndvprime
anim
heterolog
boost
challeng
vvgag
describ
figur
anim
boost
rabvgag
vsvgag
gener
significantli
higher
percentag
tnf
p
compar
mice
boost
similarli
vsvgag
induc
higher
express
unboost
mice
p
cell
coexpress
higher
rabvgag
vsvgag
boost
anim
compar
unboost
p
comparison
postchalleng
cellular
immun
respons
group
includ
studi
perform
identifi
combin
induc
robust
immun
respons
overal
vsvgag
prime
induc
gag
specif
immun
respons
higher
respons
mice
prime
rabvgag
ndvgag
figur
within
vsvgag
prime
group
boost
twice
ndvgag
induc
highest
amount
gagspecif
cell
like
mani
infecti
diseas
signific
impact
human
popul
vaccin
hiv
critic
need
along
humor
immun
cell
shown
import
control
hiv
cellular
immun
induc
trial
fail
protect
individu
hiv
result
peopl
vaccin
group
acquir
infect
compar
placebo
part
problem
thought
presenc
preexist
immun
vector
nsv
use
studi
chosen
individu
preexist
immun
rabv
vsv
ndv
vaccin
vector
gag
extens
studi
genom
easi
manipul
insert
multipl
gene
without
affect
replic
furthermor
pathogen
immunogen
extens
studi
mice
nhp
appropri
attenu
vector
develop
studi
analyz
gag
cell
respons
use
combin
nsv
vector
heterolog
combin
vector
abl
boost
gag
cell
compar
boost
control
anim
figur
expect
homolog
combin
effect
improv
respons
due
preexist
immun
vector
rabv
vsv
ndvgag
induc
significantli
higher
target
cell
respons
mice
prime
rabvgag
figur
vsvgag
figur
howev
need
consid
case
ndvgag
two
boost
immun
appli
previou
studi
rabviggag
also
abl
boost
respons
rabvgag
contain
ectodomain
transmembran
domain
vsvg
indiana
strain
hand
vsvgag
induc
higher
cell
respons
mice
prime
ndvgag
togeth
postboost
data
impli
ndvgag
vsvgag
good
candid
use
boost
vaccin
three
nsv
analyz
studi
one
interest
result
studi
ndvgag
abl
effici
boost
gagspecif
cell
rabvgag
prime
vsvgag
fail
figur
find
might
help
elucid
mechan
secondari
respons
vaccin
suspect
differ
pattern
cytokin
induct
pattern
might
respons
observ
effect
import
note
codonoptim
gag
gene
insert
clone
vsv
ndv
recombin
vector
studi
ndv
express
codonoptim
gag
publish
optim
gag
express
alter
ndv
recoveri
grew
similar
level
ndv
control
vector
furthermor
increas
gag
express
enhanc
cell
respons
determin
reduct
vvgag
titer
challeng
experi
similarli
higher
level
gag
express
vsv
optim
gag
vsv
nonoptim
gag
data
shown
rabv
express
codon
optim
gag
hand
express
higher
level
gag
cell
lysat
supernat
fact
express
level
gag
rabvn
lower
use
codonoptim
gag
compar
wildtyp
vector
one
possibl
explan
codon
optim
lead
differ
viral
replic
transcript
case
rabv
howev
gag
express
level
explain
robust
post
boost
respons
vsvgag
ndvgag
figur
c
ndv
express
least
amount
hiv
gag
vsv
express
highest
amount
gag
note
ndv
vsv
potent
induc
type
ifn
respons
might
support
effect
boost
challeng
studi
mice
done
use
vvgag
previous
publish
vvgag
viru
replic
induc
robust
respons
foreign
antigen
like
gag
mice
result
challeng
experi
show
primeboost
regimen
gener
signific
recal
respons
compar
control
figur
post
vvgag
challeng
mice
boost
ndvgag
lower
cell
respons
compar
rabvgag
vsvgag
boost
mice
would
expect
base
robust
respons
induc
ndvgag
boost
data
figur
one
differ
boost
challeng
studi
immun
schedul
day
prime
boost
compar
day
prime
challeng
howev
previou
studi
shown
good
challeng
respons
week
post
boost
ndvgag
could
potenti
due
differ
longterm
memori
cell
function
profil
cell
induc
immun
respons
determin
analyz
express
cytokin
analyz
includ
howev
level
express
latter
cytokin
compar
background
low
therefor
includ
data
shown
gener
express
coexpress
proport
magnitud
immun
respons
induc
post
boost
figur
post
challeng
figur
figur
potenti
vector
vaccin
gag
previous
establish
studi
show
rabv
vsv
ndv
compat
heterolog
primeboost
regimen
abl
enhanc
immun
respons
prime
induc
longterm
memori
cell
could
recal
challeng
ndvgag
vsvgag
elicit
strongest
post
boost
immun
respons
like
due
induct
type
interferon
respons
vsvgag
prime
mice
gener
appear
highest
respons
post
challeng
establish
compat
vaccin
regimen
rabvgag
prime
ndvgag
boost
vsvgag
boost
would
great
candid
studi
mice
macaqu
emphasi
function
cell
addit
envelop
protein
stimul
humor
respons
explor
